Roman Ivankiv
Foot Surgery · St Augustine, FLNPI 1528517331
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,566 of the $5,599 with a category attached, or 63.7%. 23 manufacturers reported payments, led by Stryker at 30.6% of the total. Reporting peaked in 2021 at $1,768 and has fallen 71.0% since, to $513 in 2025.
Across 93 payments — averaging $60.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Smith+Nephew$1K
- Organogenesis Inc.$627
- Arthrex$485
- Amgen$397
- Cardiovascular Systems Inc.$172
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$1573%
- Travel & lodging$1,87633%
- Food & beverage$3,56664%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 21 | $1,715 |
| Smith+Nephew | 14 | $1,012 |
| Organogenesis Inc. | 16 | $627 |
| Arthrex | 7 | $485 |
| Amgen | 8 | $397 |
| Cardiovascular Systems Inc. | 2 | $172 |
| Kerecis Limited | 2 | $161 |
| Paragon 28, Inc. | 1 | $148 |
| Bard Peripheral Vascular, Inc. | 1 | $134 |
| Penumbra, Inc. | 1 | $121 |
| Paratek Pharmaceuticals, Inc. | 3 | $120 |
| Tactile Systems Technology Inc | 1 | $98 |
| Abbott | 1 | $98 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $73 |
| Next Science LLC | 3 | $48 |
| Integra Lifesciences Corporation | 2 | $39 |
| Bioventus LLC | 2 | $28 |
| KCI USA, Inc. | 2 | $28 |
| Solventum Corporation | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Acera Surgical, Inc. | 1 | $19 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Embody, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Grafix$899
- STRAVIX PL$899
- Oasis$789
- PROPHECY$635
- Kerecis Omega3 Marigen$600
- PRIME SERIES$365
- KRYSTEXXA$220
- Kerecis Omega3 SurgiClose$150
- Hammertube Sterile Implant Kits$148
- PROstep$135
- Venclose Maven Catheter$134
- Penumbra System$121
- GRAFIX PL$110
- Stravix$110
- ORTHOLOC 3DI CROSSCHECK$101
- ORTHOLOC 2 LAPIFUSE$101
- CHARLOTTE$101
- PHALINX$101
How this compares
$5,599 in reported general payments places this provider in the 85th percentile of 107 foot surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 20 | $9,083 |
| Diclofenac Sodium | 24 | $636 |
| Prednisone | 50 | $332 |
| Terbinafine Hcl | 40 | $306 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 35 | $236 |
| Gabapentin | 40 | $221 |
| Ciprofloxacin Hcl | 24 | $220 |
| Ketoconazole | 16 | $185 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $180 |
| Mupirocin | 23 | $178 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $167 |
| Meloxicam | 43 | $100 |
| Triamcinolone Acetonide | 23 | $69 |
| Doxycycline Hyclate | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,012 | $9,08320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 107 foot surgery providers in Florida.
Other foot surgery in St Augustine
- Nicole GortaireSt Augustine$11K
- Larry HodsonPanama City$413K
- Bret BrennanTampa$60K
- Bradley HerbstJacksonville$20K
- Amy DunetzAventura$14K
- Than Binh NguyenTampa$13K
- Orlando CedenoJupiter$13K
- Karen LeePembroke Pines$12K
- Alix CharlesPlantation$8K
- Melissa PerlmanPembroke Pines$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.